Man Collapses Behind Trump During Oval Office Announcement
During an Oval Office press conference on Thursday, a participant collapsed behind President Donald Trump while he was speaking alongside drugmakers Eli Lilly and Novo Nordisk. The event focused on expanding Medicare coverage and lowering prices for popular obesity drugs Zepbound and Wegovy.
As the man lost consciousness, officials quickly came to his aid. Dr. Mehmet Oz, Administrator of the Centers for Medicare and Medicaid Services, supported the man’s head as he was lowered to the floor. The press was promptly escorted from the room, and it remained unclear what caused the incident.
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
White House Press Secretary Karoline Leavitt clarified that the man was a guest representing one of the attending health care companies. Roughly an hour later, President Trump resumed the event, noting that the gentleman had felt lightheaded but was recovering well. The man did not return to the Oval Office session.
President Trump also confirmed the administration’s new agreement with Eli Lilly and Novo Nordisk to broaden Medicare coverage and cut prices for the weight-loss medications.
Author’s summary: A representative fainted during President Trump’s Oval Office event announcing lower prices and expanded access to obesity drugs, later confirming he was safe.